Preemptive use of epidural magnesium sulphate to reduce narcotic requirements in orthopedic surgery  by Aly Kandil, Abir Hassan et al.
Egyptian Journal of Anaesthesia (2012) 28, 17–22Egyptian Society of Anesthesiologists
Egyptian Journal of Anaesthesia
www.elsevier.com/locate/egja
www.sciencedirect.comResearch ArticlePreemptive use of epidural magnesium sulphate
to reduce narcotic requirements in orthopedic surgeryAbir Hassan Aly Kandil *, Raafat Abd El Azim Hammad,
Mohammed Anwar El Shafei, Reem Hamdi El Kabarity,
Hala Salah El Din El OzairyAnesthesia and Intensive Care, Faculty of Medicine, Ain Shams University, EgyptReceived 13 August 2011; revised 19 October 2011; accepted 26 October 2011
Available online 3 December 2011*
90
12
E-
11
an
Pe
doKEYWORDS
Epidural analgesia;
MagnesiumCorresponding author. Addr
2, Riyadh 11555, Saudi A
379315.
mail address: abirkandil@gm
10-1849 ª 2011 Egyptian So
d hosting by Elsevier B.V.
er review under responsibility
i:10.1016/j.egja.2011.10.006
Production and h
Oess: PO B
rabia. T
ail.com
ciety of
of Egypti
osting by E
pen accessAbstract Background and objectives: As pain is one of the most common problems challenging the
anesthetist, and as regional anesthesia is a safe, inexpensive techniquewith the advantage of prolonged
postoperative analgesia. Also, we all know that Magnesium is the fourth most plentiful cation in the
body with antinociceptive properties arising from being the natural physiological calcium antagonist
and the antagonism toN-methyl-D-aspartate (NMDA) receptor. Thus, the study is a prospective, ran-
domized, double-blind study designed to evaluate analgesic efﬁcacy of magnesium sulphate when
added to epidural bupivacaine in patients undergoing orthopedic surgery in the lower limb.
Methods: After approval of the ethical committee and informed written consent 60 patients ASA I
and II, undergoing orthopedic surgery in the lower limb were enrolled to receive either bupivacaine
0.5% or bupivacaine 0.5% plus magnesium sulphate 50 mg as an initial bolus dose followed by a con-
tinuous infusion of 10 mg/h as intraoperative epidural analgesia. Postoperatively, all patients were
equipped with a patient-controlled epidural analgesia device. Heart rate, mean arterial pressure, oxy-
gen saturation, respiratory rate, pain assessment using a visual analogue scale (VAS), sedation score,
the ﬁrst time patient ask for analgesics and postoperative fentanyl consumption were recorded.ox 60679, Danah Homes Unit
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18 A.H. Aly Kandil et al.Results: VAS was signiﬁcantly less in the magnesium group during 15 and 30 min intra-operatively
and in the ﬁrst and third hour post-operatively. The postoperative rescue analgesia, as well as the
PCEA fentanyl consumption, was signiﬁcantly reduced in the magnesium group.
Conclusion: Co-administration of epidural magnesium provides better intraoperative analgesia as
well as the analgesic-sparing effect on PCEA consumption without increasing the incidence of side-
effects.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
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The goals of pre-emptive analgesia are to decrease acute pain
after tissue injury, prevent pathologic modulation of central
nervous system caused by pain, and prevent the development
of chronic pain. Regional anesthesia is an effective technique,
in this regards due to its safety, efﬁciency, and long duration of
action [1]. Research continues concerning different techniques
and drugs that could prolong the duration of regional anesthe-
sia and postoperative pain relief with minimal side effects [1].
Magnesium is the fourth most plentiful cation in the body. It
has antinociceptive effects in animal and human models of
pain [2,3]. Previous studies had proved that intrathecally
administered magnesium prolonged the duration of action of
intrathecal opioid without increasing its side effects [3]. These
effects have prompted the investigation of epidural magnesium
as an adjuvant for postoperative analgesia [4].
The purpose of this study is to detect the analgesic efﬁcacy
of epidural magnesium when administered with bupivacaine in
patients undergoing orthopedic surgery in the lower limb.
2. Methods
After obtaining the approval of the Hospital Research & Eth-
ical Committee and patient’s informed consent, 60 ASA I and
II patients of both sexes, aged 20–70 years undergoing ortho-
pedic surgeries of the lower limb were enrolled in this random-
ized, double blinded placebo-controlled study. Those who had
renal, hepatic impairment, cardiac disease, coagulopathy or
receiving anticoagulants, spine deformity or neuropathy for
any cause were excluded from the study.
Prior to surgery, we explained to the patients the epidural
technique as well as the visual analogue scale (VAS; 0: no pain;
10: worst pain) and the patient-controlled epidural analgesia
device (PCEA).
All the patients were assessed as regards the hemodynamics
including the heart rate (HR), mean arterial pressure (MAP)
and oxygen saturation (SpO2). Intravenous access had been
established and an infusion of crystalloid commenced.
Before the induction of anesthesia, an epidural catheter was
placed at the L3–L4 or L4–L5 intervertebral space under local
anesthesia with the use of loss of resistance technique, and cor-
rect position was conﬁrmed by injection of lidocaine 2% (3 ml)
with epinephrine in concentration 1:200,000. An epidural cath-
eter was then inserted into the epidural space. The level to be
blocked was up to T10. The study was done in a double blind
method using a sealed envelope technique. Patients were ran-
domly allocated to one of two equal groups. First group (con-
trol group) received 10 ml saline via epidural catheter followedby infusion of saline 2 ml/h during the surgery. Second group
(Mg group) received 50 mg magnesium sulphate (MgSO4) in
10 ml as an initial bolus dose followed by infusion of 10 mg/
h (2 ml/h) during the surgery. All patients received epidural
bupivacaine 0.5% in a dose of 1 ml/segment.
Sensory block was assessed bilaterally by using loss of tem-
perature sensation with an ice cube regarding the onset of anal-
gesia and its duration. Motor block was evaluated using a
modiﬁed Bromage scale (0: no motor block, 1: inability to raise
extended legs, 2: inability to ﬂex knees, 3: inability to ﬂex ankle
joints). During the course of operation, epidural bupivacaine
0.5% was given, if required, to achieve a block above T10 le-
vel. MAP, HR, SpO2 and respiratory rate (RR) were recorded
before and after administration of the epidural medications
and every 15 min till the end of the surgery.
When surgery was completed, all patients received PCEA
using a PCEA device (Infusomat Space, B. Braun Space,
Germany) containing fentanyl 2 lg/ml and bupivacaine
0.03% (0.3 mg/ml). The PCEA was programmed to deliver
2.5ml/h infusion with a bolus dose of 1.5 ml on demand. The
lockout interval between boluses was 6 min. The PCEA bolus
volume was titrated according to the analgesic effect or
appearance of side-effects. Patients’ ﬁrst analgesic requirement
times were recorded. The time from end of surgery till the ﬁrst
use of medication by PCEA was deﬁned as the time to the ﬁrst
requirement for postoperative epidural analgesia. A resting
pain score of 63 was considered as a satisfactory pain relief.
If patients had inadequate analgesia, supplementary rescue
analgesia with intramuscular pethidine 50 mg was available.
MAP, HR, SpO2, RR and pain assessment using VAS were re-
corded on arrival to recovery, every hour for 6 h and every 6 h
for 24 h in the postoperative period. Epidural fentanyl con-
sumption was also recorded. Patients discharged to the ward
when all hemodynamic variables were stable with fully re-
solved motor block, satisfactory pain relief, and absence of
nausea and vomiting. Adverse events related with the epidural
drugs (sedation, respiratory depression, nausea, vomiting, pro-
longed motor block) and epidural catheter were recorded
throughout the 24 h study period. Sedation was assessed with
a four-point Scale: 0: awake and alert, 1: mildly sedated, easily
aroused, 2: moderately sedated, aroused by shaking, 3: deeply
sedated, difﬁcult to be aroused by physical stimulation. A
blinded anesthesiologist who was unaware of the drug given,
performed all assessments.
Statistical presentation and analysis of this study was
conducted using the mean, standard error, student t-test, and
chi square test whenever appropriate using SPSS v 17. A
difference with p value < 0.05 was considered statistically
signiﬁcant.
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As regards the demographic data there was no signiﬁcant dif-
ference between the 2 study groups (Table 1). As regards the
intra-operative hemodynamics there is no signiﬁcant difference
between the 2 study groups (Figs. 1 and 2).
The intraoperative VAS was signiﬁcantly less in magnesium
group compared to control group after 15 and 30 min (Fig. 3).
Whereas the postoperative VAS was signiﬁcantly less in the
magnesium group in the ﬁrst and third postoperative hour
compared to control group (Fig. 4).
The time of request for postoperative analgesia was signif-
icantly delayed and the number of patients requesting postop-
erative analgesia was signiﬁcantly reduced in magnesium
group (Fig. 5).Table 1 Demographic data.
Control group (n= 30)
No %
Gender
Male 11 36.7
Female 19 63.3
Age 61.9 ± 8.21 58.57
BMI
Normal 0 0.0
Overweight 18 60.0
Obesity 12 40.0
Procedure
Rt TKR 6 20.0
Lt TKR 7 23.3
Bil TKR 17 56.7
ORIF Tibia 0 0.0
ASA
I 7 23.3
II 23 76.7
Duration of surgery (min) 40.3 ± 123
TKR= Total knee replacement, ORIF = open reduction internal ﬁxatio
of >24 Kg/m2, obesity = BMI of >30 Kg/m2. Morbid obesity = BMI o
Figure 1 The intraoperative puMoreover, the pethidine rescue analgesia consumption was
signiﬁcantly reduced in magnesium group compared to control
group (Table 2 and Fig. 5).
The total amount of fentanyl infusion over 24 h post-oper-
ative is reduced in magnesium group than control group being
296.9 ± 56.86 lg in magnesium group and 420.67 ± 112.19 lg
in control group with p value 0.0001.
No signiﬁcant differences were recorded regarding the inci-
dence of sedation or any adverse effects between groups (Table
3).
4. Discussion
The efﬁcacy of postoperative pain therapy is a crucial issue in
the functional outcome of the surgery [5]. It was evident thatMgSO4 group (n= 30)
No % p-Value
9 30.0 0.584
21 70.0
± 7.99 0.12
2 6.7 0.152
14 46.7
14 46.7
9 30.0 0.545
7 23.3
13 43.3
1 3.3
8 26.7 0.766
22 72.2
40.8 ± 129 0.72
n, ASA= American society of anesthesiologist. Over weight = BMI
f >40 Kg/m2. Duration of surgery expressed as mean ± SD.
lse rate of the study groups.
Figure 2 The intraoperative mean arterial blood pressure of study groups.
Figure 3 The intraoperative visual analogue scale of the study groups.
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Figure 4 The postoperative visual analogue score of the study groups.
20 A.H. Aly Kandil et al.epidural analgesia regardless the agent used provides better
postoperative analgesia than parental analgesia [6]. Merging
of local anesthetics with adjuvants gained widespread popular-
ity. It provides a signiﬁcant analgesia which allows the
reduction of the amount of local anesthetic and opioid admin-
istration for postoperative pain. Reducing the dose reduces the
incidence of side effects [7].The study demonstrates a signiﬁcant improvement in VAS
in the magnesium group in the intraoperative as well as in the
postoperative period. The study also showed a signiﬁcant
reduction in the number of patients requesting early postoper-
ative analgesia as well as total fentanyl consumption. This is
indicating better control of pain in the magnesium group dur-
ing both intraoperative and postoperative periods.
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Figure 5 Time request for analgesia in study groups.
Table 2 The number of patients receiving pethidine used as
rescue analgesia in the study group.
Control MgSO4 p-Value
No. % No. %
Pethidine given 21 70.0% 9 30.0% 0.002\
Amount (mg) 36.67 ± 26.04 15.00 ± 26.75 0.002\
Table 3 Complications in the study groups.
Complication Control MgSO4 p-Value
No % No %
No complication 22 73.3 24 80.0 0.753
Hypotension 5 16.7 4 13.3
Bradycardia 2 6.7 2 6.7
Wet tap 1 3.3 0 0.0
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based on the regulation of calcium inﬂux into the cell, as a cal-
cium antagonism and antagonism of N-methyl-D-aspartate
(NMDA) receptor [1,8].
This agrees with a study done by Tanmoy and colleagues
[9]. They evaluated the effect of the addition of MgSO4 as an
adjuvant to epidural Bupivacaine in the lower abdominal sur-
gery. They reported reduction in the time of onset and estab-
lishment of epidural block.
Also, it agrees with Arcioni and colleagues [10] proved that
combined intrathecal and epidural MgSO4 supplementation
reduce the postoperative analgesic requirements. Farouk and
Ibrahim [11] found that the continuous epidural magnesium
started before anesthesia provided preemptive analgesia, and
analgesic sparing effect that improved postoperative analgesia.
Also, Bilir and colleagues [4] showed that the time to ﬁrst anal-
gesia requirement was slightly longer with a signiﬁcant reduc-
tion in fentanyl consumption after starting epidural MgSO4
infusion postoperatively. While, Asokumar and colleagues
[12] found that addition of MgSO4 prolonged the median
duration of analgesia after intrathecal drug administration.
On the other hand, Ko and colleagues [13] found that peri-
operative intravenous administration of magnesium sulfate50 mg/kg does not reduce postoperative analgesic require-
ments which could be attributed to the ﬁnding that the periop-
erative intravenous administration of MgSO4 did not increase
CSF magnesium concentration due to inability to cross Blood
brain barrier.
In the present study, there were no signiﬁcant hemody-
namic changes between groups. This is in agreement with
many authors who used epidural MgSO4 [4,14], and did not re-
port any hemodynamic or respiratory instability during the
observation period.
This study did not record any neurological or epidural
drugs related complications postoperatively. The results agree
with some of the trials that have previously examined the neu-
rological complications of using the epidural MgSO4
[4,11,12,14]. Moreover, Goodman and colleagues [15], found
that inadvertent administration of larger doses MgSO4 (8.7 g
and 9.6 g) through the epidural catheter did not reveal any
neurological side effects.
The results did not reveal any signiﬁcant difference regard-
ing the sedation score. This is in agreement with Bilir et al. [4]
and El-Kerdawy [14] who did not report any case with
drowsiness or respiratory depression when using epidural
magnesium.
In conclusion, co-administration of epidural magnesium
provides better intraoperative analgesia as well as the analge-
sic-sparing effect on PCEA consumption without increasing
the incidence of side-effects compared to bupivacaine alone
in patients undergoing total knee replacement. The results of
the present investigation suggest that magnesium may be one
of the useful adjuvants to epidural analgesia.References
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